Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Pfizer Completes Acquisition of King Pharmaceuticals

By Pharmaceutical Processing | March 1, 2011

Pfizer Inc. today announced that it has combined operations
with King Pharmaceuticals, Inc. On February 28, 2011, Pfizer completed its acquisition
of King through the merger of its wholly owned subsidiary, Parker Tennessee
Corp., with and into King. King is now a wholly owned subsidiary of Pfizer.

“With the addition of King’s talented colleagues and
innovative products and technology, Pfizer will offer patients who are in need
of pain relief and pain management a broader spectrum of treatment options,”
said Ian Read, Pfizer president and chief Executive officer.

“Pfizer’s expanded portfolio also includes King’s Meridian auto- injector business for emergency drug
delivery, which develops and manufactures the EpiPen(R), and its Alpharma
animal health business, both of which are complementary to and aligned with
Pfizer’s existing businesses.” We believe we are in a position to quickly
capitalize on the benefits offered by the combination with King, including a
strengthened portfolio, immediate incremental revenues and an anticipated contribution
to steady earnings growth and shareholder value.”  

Related Articles Read More >

Building a resilient pharma supply chain
Antheia_Logo (1)
Pharma ingredient manufacturer Antheia raises $56M Series C
These are the logos of Otsuka Medical and ICU Medical.
ICU Medical, Otsuka Pharmaceutical Factory launch joint IV supply chain venture
Amgen
Amgen to spend $900M to expand U.S. biopharma manufacturing
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE